Paxmedica, Common Stock Stock Fundamentals
| PXMDDelisted Stock | USD 0.86 0.18 17.31% |
PaxMedica, Common Stock fundamentals help investors to digest information that contributes to PaxMedica, Common's financial success or failures. It also enables traders to predict the movement of PaxMedica, Pink Sheet. The fundamental analysis module provides a way to measure PaxMedica, Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PaxMedica, Common pink sheet.
PaxMedica, |
PaxMedica, Common Stock Company Return On Equity Analysis
PaxMedica, Common's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PaxMedica, Common Return On Equity | -10.47 |
Most of PaxMedica, Common's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PaxMedica, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, PaxMedica, Common Stock has a Return On Equity of -10.4696. This is 56.32% lower than that of the Biotechnology sector and 71.28% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
PaxMedica, Common Stock Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PaxMedica, Common's current stock value. Our valuation model uses many indicators to compare PaxMedica, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PaxMedica, Common competition to find correlations between indicators driving PaxMedica, Common's intrinsic value. More Info.PaxMedica, Common Stock is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PaxMedica, Common's earnings, one of the primary drivers of an investment's value.PaxMedica, Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PaxMedica, Common's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PaxMedica, Common could also be used in its relative valuation, which is a method of valuing PaxMedica, Common by comparing valuation metrics of similar companies.PaxMedica, Common is currently under evaluation in return on equity category among its peers.
PaxMedica, Fundamentals
| Return On Equity | -10.47 | ||||
| Return On Asset | -2.56 | ||||
| Current Valuation | 388.33 K | ||||
| Shares Outstanding | 7.47 M | ||||
| Shares Owned By Insiders | 8.14 % | ||||
| Shares Owned By Institutions | 1.60 % | ||||
| Number Of Shares Shorted | 637.72 K | ||||
| Price To Earning | 1.90 X | ||||
| Price To Book | 1.83 X | ||||
| EBITDA | (16.15 M) | ||||
| Net Income | (18.29 M) | ||||
| Cash And Equivalents | 9.06 K | ||||
| Total Debt | 173.54 K | ||||
| Debt To Equity | 0.07 % | ||||
| Book Value Per Share | 0.46 X | ||||
| Cash Flow From Operations | (10.77 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (11.00) X | ||||
| Target Price | 3.0 | ||||
| Market Capitalization | 5.14 M | ||||
| Total Asset | 5.68 M | ||||
| Retained Earnings | (52.03 M) | ||||
| Working Capital | 3.89 M | ||||
| Net Asset | 5.68 M |
About PaxMedica, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PaxMedica, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PaxMedica, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PaxMedica, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC. Paxmedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in PaxMedica, Pink Sheet
If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |